Fulcrum Therapeutics (FULC) EPS (Diluted) (2020 - 2026)

Fulcrum Therapeutics (FULC) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Fulcrum Therapeutics 286.57 Mn 286.57 Mn - -0.66

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.66
Dec 31, 2025 -1,328.26
Sep 30, 2025 -0.31
Jun 30, 2025 -0.28
Mar 31, 2025 -0.47
Dec 31, 2024 -1,152.41
Sep 30, 2024 -0.35
Jun 30, 2024 0.87
Mar 31, 2024 -1,052.51
Dec 31, 2023 -703.08
Sep 30, 2023 -388.48
Jun 30, 2023 -384.88
Mar 31, 2023 -511.08
Dec 31, 2022 -4,277.66
Sep 30, 2022 -586.07
Jun 30, 2022 -866.76
Mar 31, 2022 -2,312.68
Dec 31, 2021 -1,440.88
Sep 30, 2021 -2,635.30
Jun 30, 2021 -1,163.99